NO118317B - - Google Patents

Download PDF

Info

Publication number
NO118317B
NO118317B NO15800965A NO15800965A NO118317B NO 118317 B NO118317 B NO 118317B NO 15800965 A NO15800965 A NO 15800965A NO 15800965 A NO15800965 A NO 15800965A NO 118317 B NO118317 B NO 118317B
Authority
NO
Norway
Prior art keywords
parts
ether
mixture
alkyl
water
Prior art date
Application number
NO15800965A
Other languages
Norwegian (no)
Inventor
A Wynes
P Aspin
Original Assignee
Robinson E S & A Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robinson E S & A Ltd filed Critical Robinson E S & A Ltd
Publication of NO118317B publication Critical patent/NO118317B/no

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D47/00Closures with filling and discharging, or with discharging, devices
    • B65D47/04Closures with discharging devices other than pumps
    • B65D47/20Closures with discharging devices other than pumps comprising hand-operated members for controlling discharge
    • B65D47/2018Closures with discharging devices other than pumps comprising hand-operated members for controlling discharge comprising a valve or like element which is opened or closed by deformation of the container or closure
    • B65D47/2031Closures with discharging devices other than pumps comprising hand-operated members for controlling discharge comprising a valve or like element which is opened or closed by deformation of the container or closure the element being formed by a slit, narrow opening or constrictable spout, the size of the outlet passage being able to be varied by increasing or decreasing the pressure
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D35/00Pliable tubular containers adapted to be permanently or temporarily deformed to expel contents, e.g. collapsible tubes for toothpaste or other plastic or semi-liquid material; Holders therefor
    • B65D35/44Closures
    • B65D35/46Closures with valves
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D47/00Closures with filling and discharging, or with discharging, devices
    • B65D47/04Closures with discharging devices other than pumps
    • B65D47/20Closures with discharging devices other than pumps comprising hand-operated members for controlling discharge
    • B65D47/2018Closures with discharging devices other than pumps comprising hand-operated members for controlling discharge comprising a valve or like element which is opened or closed by deformation of the container or closure
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D47/00Closures with filling and discharging, or with discharging, devices
    • B65D47/04Closures with discharging devices other than pumps
    • B65D47/20Closures with discharging devices other than pumps comprising hand-operated members for controlling discharge
    • B65D47/2018Closures with discharging devices other than pumps comprising hand-operated members for controlling discharge comprising a valve or like element which is opened or closed by deformation of the container or closure
    • B65D47/2056Closures with discharging devices other than pumps comprising hand-operated members for controlling discharge comprising a valve or like element which is opened or closed by deformation of the container or closure lift valve type
    • B65D47/2062Closures with discharging devices other than pumps comprising hand-operated members for controlling discharge comprising a valve or like element which is opened or closed by deformation of the container or closure lift valve type in which the deformation raises or lowers the valve stem
    • B65D47/2075Closures with discharging devices other than pumps comprising hand-operated members for controlling discharge comprising a valve or like element which is opened or closed by deformation of the container or closure lift valve type in which the deformation raises or lowers the valve stem in which the stem is raised by the pressure of the contents and thereby opening the valve

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Closures For Containers (AREA)
  • Tubes (AREA)
  • Check Valves (AREA)
  • Steroid Compounds (AREA)

Description

Fremgangsmåte til fremstilling av 17"-alkylderivater av 19-nortestosteron. Process for the preparation of 17"-alkyl derivatives of 19-nortestosterone.

Foreliggende oppfinnelse angår frem-stillingen av en hittil ukjent gruppe av The present invention relates to the production of a previously unknown group of

blodtrykksenkende og anaboliske midler blood pressure-lowering and anabolic agents

med liten androgen aktivitet, nemlig 19-nortestosteronderivater, som i 17a-stillingen er substituert med et lavere alkylra-dikal, som inneholder 2—8 kullstoffatomer. with little androgenic activity, namely 19-nortestosterone derivatives, which are substituted in the 17a position with a lower alkyl radical, containing 2-8 carbon atoms.

De her omhandlede forbindelser kan The compounds referred to here can

gjengis av den almene strukturformel is reproduced by the general structural formula

hvor R er en lavere alkylgruppe med 2—8 where R is a lower alkyl group with 2-8

kullstoffatomer, f. eks. en etylgruppe eller carbon atoms, e.g. an ethyl group or

en like eller forgrenet propyl-, butyl-, pen-tyl-, heksyl-, heptyl- eller oktylgruppe. a straight or branched propyl, butyl, pentyl, hexyl, heptyl or octyl group.

De her omhandlede forbindelser er The compounds in question here are

verdifulle anaboliske midler, dvs. de frem-mer kvelstoffretensjonen. De har denne valuable anabolic agents, i.e. they promote nitrogen retention. They have this one

virkning ved en dosering som bare medfø-rer en meget liten grad av androgen aktivitet. Det er vel kjent at testosteronpropio-nat er et virksomt anabolisk middel, men effect at a dosage that only results in a very small degree of androgenic activity. It is well known that testosterone propionate is an effective anabolic agent, but

denne forbindelses kliniske nytte til dette this compound's clinical utility to this

formål er sterkt begrenset, fordi de andro-gene virkninger er uønsket hos mange pa-sienter. Ved anvendelse av de her omhandlede forbindelser er de virksomme anaboliske doser så små at langvarig inngift purpose is severely limited, because the androgenic effects are undesirable in many patients. When using the compounds referred to here, the effective anabolic doses are so small that long-term administration

praktisk talt ikke har uønskede bivirknin-ger. have practically no unwanted side effects.

Et annet viktig anvendelsesområde for Another important area of application for

disse forbindelser skyldes deres virkning these compounds are due to their action

mot forhøyet blodtrykk, som ikke finnes against high blood pressure, which does not exist

hos 19-nortestosteron eller dettes 17-me-tylderivat. De her omhandlede forbindelser er særlig virksomme til overvinning av den blodtrykkforhøyelse som tilveiebringes av binyrebarkhormonet desoksy-corticos-teron. in 19-nortestosterone or its 17-methyl derivative. The compounds referred to here are particularly effective in overcoming the increase in blood pressure caused by the adrenal cortical hormone desoxycorticosterone.

Ifølge oppfinnelsen fremstilles de omhandlede forbindelser ved at en 3-okso-17a-alkyl-5(10)-østren-17-ol, i hvilken alkylgruppen har 2—8 kullstoffatomer, isomeriseres til en 17-alkyl-19-nortestosteron. Isomeriseringen kan tilveiebringes under innflytelse av et basisk middel, f. eks. na-triumhydroksyd i vandig metanol, eller et surt middel, såsom saltsyre eller p-toluen-sulfonsyre i vandig metanol, hvorved dob-beltbindingen vandrer fra 5—10-stillingen til 4—5-stillingen, hvorved der fåes en forbindelse av den ønskede konfigurasjon. According to the invention, the compounds in question are prepared by isomerizing a 3-oxo-17a-alkyl-5(10)-estren-17-ol, in which the alkyl group has 2-8 carbon atoms, to a 17-alkyl-19-nortestosterone. The isomerization can be brought about under the influence of a basic agent, e.g. sodium hydroxide in aqueous methanol, or an acidic agent, such as hydrochloric acid or p-toluenesulfonic acid in aqueous methanol, whereby the double bond migrates from the 5-10 position to the 4-5 position, whereby a compound of the desired configuration.

En 3-okso-17a-alkyl-5(10)-østren-17-ol fremstilles hensiktsmessig ved en reak-sjonsrekke, som omfatter etynylering med acetylen av en lavere alkyleter av østron. katalytisk hydrering av 17-etynylgruppen til en 17-etylgruppe og en reduksjon av Birch-typen av den dannede 17a-alkyl-østradiol-3-monoalkyleter med litium og ammoniakk, fulgt av en måteholden sur hydrolyse. Ved en hensiktsmessig forand-ring av denne fremgangsmåte underkastes det produkt som fåes ved Birch-reduksjo-nen: en 17a-alkyl-3-alkoksy-2,5(10)-øst-radien-17-ol, en kraftigere sur hydrolyse, hvorved enoleter-resten i 3-stillingen opp-spaltes, den dannede 3-enol-forbindelse ke-toniseres, og 5—10-dobbeltbindingen flyt-tes til konjugert stilling i forhold til 3-ke-ton-gruppen i én operasjon i samme reak-sjonsbeholder, uten at det er nødvendig å isolere den som mellomprodukt dannede 3-okso-17a-alkyl-5 (10) -østren-17-ol. Det vil være klart at den direkte omdannelse av 17cc-alkyl-3-alkoksy-2,5 (10) -østradien-17-ol til en 17-alkyl-19-nortestosteron må foregå gjennom isomeriseringen av en 3-okso-17a-alkyl-5(10)-østren-17-ol til en 17-alkyl-19-nortestosteron. Ved den direkte omdannelse av den homoannulære ukon-jugerte dien-17a-alkyl-3-alkoksy-2,5(10)-østradien-17-ol opptrer 3-okso-17cx-alkyl-5(10)-østren-17-ol i reaksjonsblandingen som et uisolert mellomprodukt som isomeriseres til 17-alkyl-19-nortestosteron. På liknende måte kan 3-okso-17a-alkyl-5(10)-østren-17-olen foreligge som et uisolert mellomprodukt ved omdannelse av en 17n-alkyl-3-alkoksy-l,3,5(10)-østratrien-17-ol A 3-oxo-17a-alkyl-5(10)-estren-17-ol is conveniently prepared by a series of reactions, which comprise ethynylation with acetylene of a lower alkyl ether of estrone. catalytic hydrogenation of the 17-ethynyl group to a 17-ethyl group and a Birch-type reduction of the formed 17α-alkyl-estradiol-3-monoalkyl ether with lithium and ammonia, followed by mild acid hydrolysis. In an appropriate modification of this method, the product obtained by the Birch reduction: a 17a-alkyl-3-alkoxy-2,5(10)-est-radien-17-ol, is subjected to a stronger acid hydrolysis, whereby the enol ether residue in the 3-position is cleaved, the formed 3-enol compound is ketonized, and the 5-10 double bond is moved to a conjugated position in relation to the 3-ketone group in one operation in the same reaction vessel, without it being necessary to isolate the 3-oxo-17a-alkyl-5 (10)-estren-17-ol formed as an intermediate product. It will be clear that the direct conversion of 17cc-alkyl-3-alkoxy-2,5(10)-estradien-17-ol to a 17-alkyl-19-nortestosterone must proceed through the isomerization of a 3-oxo-17a- alkyl-5(10)-estren-17-ol to a 17-alkyl-19-nortestosterone. In the direct conversion of the homoannular unconjugated diene-17α-alkyl-3-alkoxy-2,5(10)-estradien-17-ol, 3-oxo-17c-alkyl-5(10)-estrene-17- ol in the reaction mixture as an unisolated intermediate which is isomerized to 17-alkyl-19-nortestosterone. Similarly, the 3-oxo-17a-alkyl-5(10)-estren-17-ol can be present as an unisolated intermediate by conversion of a 17n-alkyl-3-alkyl-1,3,5(10)-estratriene- 17-ol

til en 17-alkyl-19-nortestosteron. to a 17-alkyl-19-nortestosterone.

Forbindelser av den her omhandlede art med særlig god aktivitet som ovenfor omtalt, og som kan fremstilles ved fremgangsmåten ifølge oppfinnelse er sådanne, i hvilke alkylgruppen er en etylgruppe. Også forbindelser i hvilke alkylgruppen er en propylgruppe, er særlig vel egnet. Compounds of the kind referred to here with particularly good activity as mentioned above, and which can be produced by the method according to the invention, are those in which the alkyl group is an ethyl group. Compounds in which the alkyl group is a propyl group are also particularly suitable.

Isomeriseringen gjennomføres ifølge oppfinnelsen fortrinsvis ved hjelp av en mineralsyre. According to the invention, the isomerization is carried out preferably with the aid of a mineral acid.

Ved en særlig egnet utførelsesform for fremgangsmåten ifølge oppfinnelsen går der ut fra 17a-etyl-3-metoksy-2,5(10)-øst-radien-17-ol, og 3-okso-17a-etyl-5(10)-østren-17-olen foreligger da som et uisolert mellomprodukt som isomeriseres til 17-etyl-19-nortestosteron ved behandling med mineralsyre. In a particularly suitable embodiment of the method according to the invention, the starting point is 17a-ethyl-3-methoxy-2,5(10)-est-radien-17-ol, and 3-oxo-17a-ethyl-5(10)- estren-17-ol is then present as an unisolated intermediate product which is isomerised to 17-ethyl-19-nortestosterone when treated with mineral acid.

Fremgangsmåten ifølge oppfinnelsen vil bli nærmere forklart i nedenstående ut-førelseseksempler. I disse eksempler betyr deler vektsdeler. The method according to the invention will be explained in more detail in the examples below. In these examples, parts means parts by weight.

Eksempel 1. Example 1.

Til en omrørt blanding av 8,5 deler magnesium i 140 deler eter settes der 5 deler allylbromid i 15 deler eter. I løpet av 45 minutter tilsettes det derpå en blanding av 20 deler av metyleteren av østron og 95 deler allylbromid i 630 deler eter. Etter 3 timers koking under tilbakeløpskjøling av-kjøles blandingen til 0° C, hvorpå den gjentatte ganger vaskes med 10 pst.'s am-moniumkloridoppløsning og dernest med vann, tørkes over vannfritt natriumsulfat, filtreres og inndampes. Resten opptas i eter. Eteroppløsningen konsentreres delvis og fortynnes med petroleter. Det således dannede krystallinske 17a-allyl-3-metoksy-1,3,5(10)-estratrien-17-ol smelter ved ca. 91—91,5° C. 5 parts of allyl bromide in 15 parts of ether are added to a stirred mixture of 8.5 parts of magnesium in 140 parts of ether. In the course of 45 minutes, a mixture of 20 parts of the methyl ether of estrone and 95 parts of allyl bromide in 630 parts of ether is then added. After boiling for 3 hours under reflux, the mixture is cooled to 0° C., after which it is repeatedly washed with 10% ammonium chloride solution and then with water, dried over anhydrous sodium sulfate, filtered and evaporated. The rest is taken up in ether. The ether solution is partially concentrated and diluted with petroleum ether. The crystalline 17α-allyl-3-methoxy-1,3,5(10)-estratrien-17-ol thus formed melts at approx. 91-91.5° C.

En blanding av 11,5 deler 17«-allyl-3-metoksy-l,3,5(10)-østratrien-17-ol, 3 deler A mixture of 11.5 parts 17'-allyl-3-methoxy-1,3,5(10)-estratrien-17-ol, 3 parts

trekull, som inneholder 5 pst. palladium, og 160 deler etanol hydreres, inntil der er absorbert en mol vannstoff. Dernest filtreres blandingen under anvendelse av et filterhjelpestoff, og filtratet inndampes under vakuum. Resten omkrystalliseres fra en blanding av eter og metanol, hvorved det fåes 17a-propyl-3-metoksy-l,3,5(10)-østratrien-17-ol, som smelter ved ca. 93— 94° C. charcoal, which contains 5 per cent palladium, and 160 parts of ethanol are hydrated until one mole of water has been absorbed. Next, the mixture is filtered using a filter aid, and the filtrate is evaporated under vacuum. The residue is recrystallized from a mixture of ether and methanol, whereby 17α-propyl-3-methoxy-1,3,5(10)-estratrien-17-ol is obtained, which melts at approx. 93— 94° C.

Til en omrørt blanding av 6 deler 17a-propyl-3-metoksy-l,3,5(10)-østratrien-17-ol i 500 deler ammoniakk og 140 deler eter settes 7 deler litium i løpet av 20 min. Blandingen omrøres i 30 minutter, hvoretter det dråpevis i løpet av en time tilsettes 46 deler etanol. Omrøringen fortsettes, inntil all ammoniakk er forsvunnet. Derpå tilsettes der vann, og eterlaget skilles fra, vaskes med vann, tørkes over vannfritt natriumsulfat, filtreres og inndampes. Krystallisasjonen fra en blanding av eter i metanol gir 17a-propyl-3-metok-sy-2,5(10)-østradien-17-ol, som smelter ved ca. 150—152° C. To a stirred mixture of 6 parts of 17a-propyl-3-methoxy-1,3,5(10)-estratrien-17-ol in 500 parts of ammonia and 140 parts of ether, 7 parts of lithium are added over the course of 20 minutes. The mixture is stirred for 30 minutes, after which 46 parts of ethanol are added dropwise over the course of an hour. The stirring is continued until all the ammonia has disappeared. Water is then added, and the ether layer is separated, washed with water, dried over anhydrous sodium sulphate, filtered and evaporated. The crystallization from a mixture of ether in methanol gives 17α-propyl-3-methoxy-sy-2,5(10)-estradien-17-ol, which melts at approx. 150—152° C.

En blanding av 18 deler 17a-propyl-3-metoksy-2,5(10)-østradien-17-ol, 320 deler metanol, 80 deler vann og 18 deler konsentrert saltsyre kokes under tilbakeløpskjø-ling i 5 minutter, hvorpå den stilles 15 minutter i varmt vann. Det tilsettes så meget varmt vann at blandingen blir uklar. Ved henstand utfelles 17-propyl-19-nortestosteron, som etter krystallisasjon fra en blanding av aceton og petroleter smelter ved 120—122° C. A mixture of 18 parts of 17α-propyl-3-methoxy-2,5(10)-estradien-17-ol, 320 parts of methanol, 80 parts of water and 18 parts of concentrated hydrochloric acid is boiled under reflux for 5 minutes, after which it is allowed to stand 15 minutes in warm water. So much hot water is added that the mixture becomes cloudy. On standing, 17-propyl-19-nortestosterone precipitates, which after crystallization from a mixture of acetone and petroleum ether melts at 120-122°C.

Eksempel 2. Example 2.

Til en omrørt suspensjon av 16,5 deler av metyleteren av østron i 300 deler eter settes det en oppløsning av butyllitium fremstilt av 115 deler 1-brombutan og 6,7 deler litium i 600 deler eter. Omrøringen fortsettes i en time, hvoretter blandingen spaltes med metanol og fortynnet svovel-syre samt ekstraheres med eter. Den fremkomne ekstrakt vaskes med mettet natri-umkloridoppløsning, tørkes over vannfritt natriumsulfat, filtreres og inndampes under kvelstoff. Resten krystalliseres av metanol og vann og anbringes derpå i ben-zenoppløsning på en kromatograferings-søyle, som inneholder 1000 deler alumini-umoksyd. Søylen vaskes med 1800 deler av en 10 pst.'s oppløsning av petroleter i benzen og elueres derpå med 9000 deler av en 10 pst.'s oppløsning av petroleter i benzen. Det fremkomne eluat inndampes, og resten omkrystalliseres av vandig metanol, hvorved der fåes 3-metoksy-17a-butyl-l,3,5(10)-østratrien-17(3-ol. To a stirred suspension of 16.5 parts of the methyl ether of estrone in 300 parts of ether is added a solution of butyllithium prepared from 115 parts of 1-bromobutane and 6.7 parts of lithium in 600 parts of ether. Stirring is continued for one hour, after which the mixture is split with methanol and dilute sulfuric acid and extracted with ether. The resulting extract is washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered and evaporated under nitrogen. The residue is crystallized from methanol and water and then placed in benzene solution on a chromatography column containing 1000 parts of alumina. The column is washed with 1800 parts of a 10% solution of petroleum ether in benzene and then eluted with 9000 parts of a 10% solution of petroleum ether in benzene. The resulting eluate is evaporated, and the residue is recrystallized from aqueous methanol, whereby 3-methoxy-17a-butyl-1,3,5(10)-estratriene-17(3-ol is obtained.

Til en oppløsning av 37,2 deler av denne forbindelse i 500 deler eter og 500 deler flytende ammoniakk settes det 3,5 deler korte stykker litiumtråd under omrøring. Den mørkeblå oppløsning omrøres i 10 minutter, hvoretter der i løpet av 15 minutter dråpevis tilsettes 32 deler metanol til avfarging av oppløsningen. Dernest tilsettes det langsomt ytterligere 56 deler metanol, og når det meste av ammoniakken er fordampet, tilsettes det 1100 deler eter og 700 deler vann under omrøring. Det or-ganiske lag skilles fra, vaskes med mettet natriumkloridoppløsning, tørkes over natriumsulfat, filtreres og konsentreres under vakuum. Til den oljeaktige rest settes det 1110 deler metanol og 500 deler vann, hvorpå blandingen oppvarmes til kokning under tilbakeløpskjøling. Dernest tilsettes det 240 deler konsentrert saltsyre, og ko-kingen under tilbakeløpskjøling fortsettes i 6 minutter. Dernest ekstraheres blandingen med eter. Eteroppløsningen vaskes med en mettet oppløsning av natriumklo-rid, tørkes over natriumsulfat, filtreres og inndampes under vakuum. Resten anbringes i benzen på en kromatografisk søyle, som inneholder 350 deler silikagel. Søylen vaskes med 500 deler benzen og derpå med 3000 deler av en 10 pst.'s oppløsning av etylacetat i benzen. Eluering med 2000 deler av en 20 pst.'s oppløsning av etylacetat i benzen, konsentrering av eluatet og krystallisasjon fra vandig metanol gir 17-butyl-19-nortestosteron, som smelter ved ca. 127—128° C. To a solution of 37.2 parts of this compound in 500 parts of ether and 500 parts of liquid ammonia, 3.5 parts of short pieces of lithium wire are added while stirring. The dark blue solution is stirred for 10 minutes, after which 32 parts of methanol are added dropwise over the course of 15 minutes to decolorize the solution. Next, a further 56 parts of methanol are slowly added, and when most of the ammonia has evaporated, 1100 parts of ether and 700 parts of water are added with stirring. The organic layer is separated, washed with saturated sodium chloride solution, dried over sodium sulfate, filtered and concentrated under vacuum. 1110 parts of methanol and 500 parts of water are added to the oily residue, after which the mixture is heated to boiling under reflux cooling. Next, 240 parts of concentrated hydrochloric acid are added, and the boiling under reflux cooling is continued for 6 minutes. The mixture is then extracted with ether. The ether solution is washed with a saturated solution of sodium chloride, dried over sodium sulfate, filtered and evaporated under vacuum. The residue is placed in benzene on a chromatographic column containing 350 parts of silica gel. The column is washed with 500 parts of benzene and then with 3000 parts of a 10% solution of ethyl acetate in benzene. Elution with 2000 parts of a 20% solution of ethyl acetate in benzene, concentration of the eluate and crystallization from aqueous methanol gives 17-butyl-19-nortestosterone, which melts at approx. 127-128° C.

Eksempel 3. Example 3.

Når det ved den i det foregående eksempel beskrevne fremgangsmåte isteden-for 1-brombutan anvendes en ekvivalent mengde 1-bromoktan, fåes det 17-oktyl-19-nortestosteron. Denne forbindelses in-frarøde absorbsjonsspektrum viser maksi-ma ved 2,8 og 6,05|i. Det ultrafiolette absorbsjonsspektrum viser et maksimum ved 240,5 mii med en molekylær ekstinksjons-koeffisient på 17.000. When an equivalent amount of 1-bromooctane is used instead of 1-bromobutane in the method described in the previous example, 17-octyl-19-nortestosterone is obtained. The infrared absorption spectrum of this compound shows maxima at 2.8 and 6.05 µm. The ultraviolet absorption spectrum shows a maximum at 240.5 mii with a molecular extinction coefficient of 17,000.

Eksempel 4. Example 4.

En blanding av 10 deler 17«-etynyl-3-metoksy-l,3,5(10)-østratrien-17-ol, 2,5 deler av en katalysator, bestående av trekull med 5 pst. palladium, og 50 deler dioksan rystes i berøring med en vannstoffatmosfære, inntil det er brukt 2 molekvivalenter vannstoff. Katalysatoren fjernes ved filtrering, og den etter filtratets konsentrering tilbakeværende rest renses ved omkrystallisasjon fra en blanding av eter og petroleter. På denne måte fåes det 17a-etyl-3-metoksy-l,3,5(10)-østratrien-17-ol som smelter ved ca. 88—89° C. A mixture of 10 parts of 17"-ethynyl-3-methoxy-1,3,5(10)-estratrien-17-ol, 2.5 parts of a catalyst, consisting of charcoal with 5% palladium, and 50 parts of dioxane shaken in contact with a hydrogen atmosphere, until 2 mole equivalents of hydrogen have been used. The catalyst is removed by filtration, and the residue remaining after the concentration of the filtrate is purified by recrystallization from a mixture of ether and petroleum ether. In this way, 17α-ethyl-3-methoxy-1,3,5(10)-estratrien-17-ol is obtained which melts at approx. 88-89° C.

En oppløsning av 50 deler av 17«-etyl-3-metoksy-l,3,5(10)-østratrien-17-ol i 710 deler eter fortynnes med 2500 deler flytende ammoniakk. Ved de følgende operasjoner, inntil reaksjonsblandingen fortynnes med vann, omrøres den hele tiden, og den holdes på et tilnærmelsesvis konstant volum ved tilsetning av i alt 2100 deler eter i porsjoner til erstatning for den ammoniakk som kontinuerlig forsvinner ved fordampning. A solution of 50 parts of 17"-ethyl-3-methoxy-1,3,5(10)-estratrien-17-ol in 710 parts of ether is diluted with 2500 parts of liquid ammonia. In the following operations, until the reaction mixture is diluted with water, it is constantly stirred, and it is kept at an approximately constant volume by the addition of a total of 2100 parts of ether in portions to replace the ammonia which is continuously lost by evaporation.

Oppløsningen av 17a-etyl-3-metoksy-l,3,5(10)-østratrien-17-ol i eter og flytende ammoniakk behandles i et tidsrom på 35 minutter ved tilsetning av ialt 35 deler litium i små porsjoner. The solution of 17α-ethyl-3-methoxy-1,3,5(10)-estratrien-17-ol in ether and liquid ammonia is treated over a period of 35 minutes by adding a total of 35 parts of lithium in small portions.

Etter ennå en time tilsettes det i lø-pet av 3 timer 240 deler etanol i små porsjoner, og omrøringen fortsettes i adskillige timer. Det tilsettes 1000 deler vann, og den eteriske fase vaskes med adskillige porsjoner vann, hvorpå den tørkes og konsentreres. Den rest som fåes ved inndam-ning av den eteriske oppløsning, omrøres med en blanding av 200 deler metanol og 1 del pyridin, og den fremkomne suspensjon avkjøles i flere timer. Det krystallinske produkt samles på et filter og vaskes med 120 deler kold metanol. Den fremkomne forbindelse er 17a-etyl-3-metoksy-2,5(10)-østradien-17-ol, som smelter ved ca. 127—128° C. After another hour, 240 parts of ethanol are added in small portions over the course of 3 hours, and stirring is continued for several hours. 1000 parts of water are added, and the ethereal phase is washed with several portions of water, after which it is dried and concentrated. The residue obtained by mixing the ethereal solution is stirred with a mixture of 200 parts methanol and 1 part pyridine, and the resulting suspension is cooled for several hours. The crystalline product is collected on a filter and washed with 120 parts of cold methanol. The resulting compound is 17α-ethyl-3-methoxy-2,5(10)-estradien-17-ol, which melts at approx. 127-128° C.

En blanding av 1,25 deler 17a-etyl-3-metoksy-2,5(10)-østradien-17-ol, 24 deler metanol og 4 deler eddiksyre oppvarmes under tilbakeløpskjøling i 5 minutter. Det tilsettes 150 deler vann, og blandingen ned-kjøles i flere timer. Det utfelte produkt samles på et filter og tørkes. Ved omkrystallisasjon fra en blanding av aceton og petroleter fåes det 17a-etyl-3-okso-5(10)-østren-17-ol, som smelter ved ca. 134— 136° C. A mixture of 1.25 parts of 17α-ethyl-3-methoxy-2,5(10)-estradien-17-ol, 24 parts of methanol and 4 parts of acetic acid is heated under reflux for 5 minutes. 150 parts of water are added, and the mixture is cooled down for several hours. The precipitated product is collected on a filter and dried. By recrystallization from a mixture of acetone and petroleum ether, 17a-ethyl-3-oxo-5(10)-estren-17-ol is obtained, which melts at approx. 134— 136° C.

En blanding av 10 deler 17a-etyl-3-okso-5(10)-østren-17-ol, 160 deler metanol, 20 deler vann og 7 deler konsentrert saltsyre omrøres i 2 timer ved værelsestemperatur, hvorpå den avkjøles og henstilles ved 0° C i 2 timer. Blandingen filtreres ved en liten mengde uoppløselig materi-ale, og filtratet fortynnes under konstant omrøring med 500 deler vann. Dernest av-kjøles blandingen til ca. 0—5° C, hvorpå den filtreres. Det krystallinske produkt kan renses ved omkrystallisasjon fra vandig metanol eller fra en blanding av aceton og petroleter. På denne måte fåes det 17-etyl-19-nortestosteron, som smelter ved ca. 140—141° C. A mixture of 10 parts of 17α-ethyl-3-oxo-5(10)-estren-17-ol, 160 parts of methanol, 20 parts of water and 7 parts of concentrated hydrochloric acid is stirred for 2 hours at room temperature, after which it is cooled and allowed to stand at 0 ° C for 2 hours. The mixture is filtered through a small amount of insoluble material, and the filtrate is diluted under constant stirring with 500 parts of water. The mixture is then cooled to approx. 0—5° C, after which it is filtered. The crystalline product can be purified by recrystallization from aqueous methanol or from a mixture of acetone and petroleum ether. In this way, 17-ethyl-19-nortestosterone is obtained, which melts at approx. 140-141° C.

Eksempel 5. Example 5.

En blanding av 36 deler 17a-etyl-3-metoksy-2,5(10)-østradien-17-ol, 475 deler metanol, 70 deler vann og 25 deler konsentrert saltsyre omrøres 2 timer ved værelsestemperatur, hvorpå den henstilles ved 0— 10° C i ca. 2 timer. Blandingen filtreres fra en liten mengde uoppløselig mate-riale, og filtratet fortynnes under konstant omrøring med 2000 deler vann. Dernest av-kjøles blandingen til ca. 0—5° C, og det krystallinske produkt samles på et filter. Omkrystallisasjon fra vandig metanol eller fra en blanding av aceton og petroleter gir rent 17-etyl-19-nortestosteron, som smelter ved ca. 140—141° C. A mixture of 36 parts of 17α-ethyl-3-methoxy-2,5(10)-estradien-17-ol, 475 parts of methanol, 70 parts of water and 25 parts of concentrated hydrochloric acid is stirred for 2 hours at room temperature, after which it is allowed to stand at 0— 10° C for approx. 2 hours. The mixture is filtered from a small amount of insoluble material, and the filtrate is diluted with constant stirring with 2000 parts of water. The mixture is then cooled to approx. 0-5° C, and the crystalline product is collected on a filter. Recrystallization from aqueous methanol or from a mixture of acetone and petroleum ether gives pure 17-ethyl-19-nortestosterone, which melts at approx. 140-141° C.

På samme måte gir 17a-etyl-3-etoksy-2,5(10)-østradien-17-ol (fremstilt ved etynylering av østron-etyl-eter fulgt av hydrering av etynylgruppen og reduksjon av det dannede produkt med litium og ommo-niakk) 17-etyl-19-nortestosteron ved behandling med mineralsyre som ovenfor beskrevet. Similarly, 17α-ethyl-3-ethoxy-2,5(10)-estradien-17-ol (prepared by ethynylation of estrone ethyl ether followed by hydrogenation of the ethynyl group and reduction of the product formed with lithium and ommo- niakk) 17-ethyl-19-nortestosterone by treatment with mineral acid as described above.

Eksempel 6. Example 6.

7,8 deler kalium, vasket med toluol, tertiær amylalkohol og eter, settes til 125 deler tertiær amylalkohol, og den omrørte reaksjonsblanding oppvarmes under til-bakeløpskjøling i en kvelstof f atmosfære i 2 timer. Dernest avkjøles det til ca. 0° C og det tilsettes en oppløsning av 24 deler 1- oktyn i 90 deler eter. Etter omrøring av blandingen i ennå 1 time tilsettes det hurtig en suspensjon av 5,7 deler østron-me-tyleter i eter. Reaksjonsblandingen omrø-res i en kvelstoffatmosfære ved ca. 0° C i ennå 5 timer, hvoretter den får lov til å anta værelsestemperatur, og den omrøres ytterligere i 16 timer. Det avkjøles på ny til 0° C, og produktet blandes godt med en oppløsning av 15 deler ammoniumklorid i 150 deler vann. Den eteriske fase skilles fra, vaskes med adskillige porsjoner am-moniumkloridoppløsning og med vann, tørkes og konsentreres til en brun rest-olje. En blanding av 4 deler av dette rå-produkt som overveiende er 17«-oktynyl-3-metoksy-l,3,5(10)-østratrien-17-ol, 1 del 5 pst.'s palladium på trekull som katalysator og 75 deler dioksan, rystes i berøring med en vannstoffatmosfære, inntil vann-stoffabsorbsjonen, som i begynnelsen er meget hurtig, er blitt meget langsom. På dette tidspunkt vil det være forbrukt opp til tilnærmelsesvis 2 molekvivalenter vannstoff. Katalysatoren fjernes ved filtrering, 7.8 parts of potassium, washed with toluene, tertiary amyl alcohol and ether, are added to 125 parts of tertiary amyl alcohol, and the stirred reaction mixture is heated under reflux in a nitrogen atmosphere for 2 hours. It is then cooled to approx. 0° C and a solution of 24 parts of 1-octyne in 90 parts of ether is added. After stirring the mixture for a further 1 hour, a suspension of 5.7 parts of estrone methyl ether in ether is quickly added. The reaction mixture is stirred in a nitrogen atmosphere at approx. 0° C. for a further 5 hours, after which it is allowed to assume room temperature, and it is further stirred for 16 hours. It is cooled again to 0° C, and the product is mixed well with a solution of 15 parts ammonium chloride in 150 parts water. The ethereal phase is separated, washed with several portions of ammonium chloride solution and with water, dried and concentrated to a brown residual oil. A mixture of 4 parts of this crude product which is predominantly 17"-octynyl-3-methoxy-1,3,5(10)-estratrien-17-ol, 1 part 5% palladium on charcoal as catalyst and 75 parts dioxane, is shaken in contact with a hydrogen atmosphere, until the water-substance absorption, which is initially very rapid, has become very slow. At this point, up to approximately 2 mole equivalents of water will have been consumed. The catalyst is removed by filtration,

og den rest som er tilbake etter konsentrering av filtratet, renses ved kromatografisk fraksjonering på en silikagelsøyle eller ved omkrystallisasjon fra metanol. På denne måte fåes det 17a-oktyl-3-metok-sy-l,3,5(10)-østratrien-17-ol, som smelter ved ca. 80—81° C. and the residue that remains after concentration of the filtrate is purified by chromatographic fractionation on a silica gel column or by recrystallization from methanol. In this way, 17a-octyl-3-methoxy-syl-1,3,5(10)-estratrien-17-ol is obtained, which melts at approx. 80-81° C.

En oppløsning av 2,5 deler 17a-oktyl-3-metoksy-l,3,5(10)-østratrien-17-ol i 70 deler eter fortynnes med 205 deler flytende ammoniakk. Denne omrørte oppløsning behandles i et tidsrom på 30 minutter ved tilsetning av i alt 2,5 deler litium i små porsjoner. Etter ennå 1 time tilsettes det i løpet av 3 timer 20 deler etanol i små porsjoner, og omrøringen fortsettes i flere timer. Under de forutgående operasjoner er ytterligere 70 deler eter gradvis blitt til-satt til erstatning for noe av ammoniakken, som er gått tapt ved fordampning. Det tilsettes 80 deler vann, og den eteriske fase vaskes med flere porsjoner vann, hvoretter den tørkes og konsentreres. Den ved inndampning av den eteriske oppløsning fremkomne rest vaskes med et lite volum kold metanol, som inneholder ca. 1 pst. py~ ridin, hvorpå det renses ved omkrystallisasjon fra en blanding av eter og metanol. På denne måte fåes det 17a-oktyl-3-me-toksy-2,5(10)-østradien-17-ol, som smelter ved ca. 50—55° C. En blanding av 1,1 del av denne forbindelse, 24 deler metanol, 6 deler vann og 1,2 deler konsentrert saltsyre oppvarmes under tilbakeløpskjøling i 10 minutter, avkjøles og fortynnes med flere ganger sitt volum vann. Rensing av det utfelte produkt ved krystallisasjon fra vandig metanol gir 17-oktyl-19-nortestosteron, som smelter ved ca. 120— 122° C. A solution of 2.5 parts of 17α-octyl-3-methoxy-1,3,5(10)-estratrien-17-ol in 70 parts of ether is diluted with 205 parts of liquid ammonia. This stirred solution is treated over a period of 30 minutes by adding a total of 2.5 parts of lithium in small portions. After a further 1 hour, 20 parts of ethanol are added in small portions over the course of 3 hours, and the stirring is continued for several hours. During the preceding operations, a further 70 parts of ether have gradually been added to replace some of the ammonia, which has been lost by evaporation. 80 parts of water are added, and the ethereal phase is washed with several portions of water, after which it is dried and concentrated. The residue resulting from evaporation of the ethereal solution is washed with a small volume of cold methanol, which contains approx. 1 percent pyridine, after which it is purified by recrystallization from a mixture of ether and methanol. In this way, 17a-octyl-3-me-thoxy-2,5(10)-estradien-17-ol is obtained, which melts at approx. 50—55° C. A mixture of 1.1 part of this compound, 24 parts of methanol, 6 parts of water and 1.2 parts of concentrated hydrochloric acid is heated under reflux for 10 minutes, cooled and diluted with several times its volume of water. Purification of the precipitated product by crystallization from aqueous methanol yields 17-octyl-19-nortestosterone, which melts at approx. 120— 122° C.

Claims (3)

1. Fremgangsmåte til fremstilling av 17a-alkylderivater av 19-nortestosteron med blodtrykksenkende og anabolisk virkning og med liten androgen aktivitet, karakterisert ved at en 3-okso-17a-alkyl-5(10)-østren-17-ol, i hvilken alkylgruppen har 2—8 kullstoffatomer, isomeriseres til en 17a-alkyl-19-nortestosteron, fortrinsvis ved hjelp av en mineralsyre.1. Process for the production of 17a-alkyl derivatives of 19-nortestosterone with blood pressure-lowering and anabolic effects and with little androgenic activity, characterized in that a 3-oxo-17a-alkyl-5(10)-estren-17-ol, in which the alkyl group has 2-8 carbon atoms, is isomerized to a 17a-alkyl-19-nortestosterone, preferably with the help of a mineral acid. 2. Fremgangsmåte ifølge påstand karakterisert ved at alkylgruppen er en etylgruppe.2. Process according to claim characterized in that the alkyl group is an ethyl group. 3. Fremgangsmåte ifølge påstand 1, karakterisert ved at alkylgruppen er en propylgruppe.3. Process according to claim 1, characterized in that the alkyl group is a propyl group.
NO15800965A 1964-05-11 1965-05-08 NO118317B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1957364A GB1107403A (en) 1964-05-11 1964-05-11 Plastic tubes for dispensing pastey or liquid substances

Publications (1)

Publication Number Publication Date
NO118317B true NO118317B (en) 1969-12-08

Family

ID=10131626

Family Applications (1)

Application Number Title Priority Date Filing Date
NO15800965A NO118317B (en) 1964-05-11 1965-05-08

Country Status (9)

Country Link
BE (1) BE663679A (en)
CH (1) CH416451A (en)
DE (1) DE1297536B (en)
DK (1) DK113413B (en)
GB (1) GB1107403A (en)
LU (1) LU48573A1 (en)
NL (1) NL6505978A (en)
NO (1) NO118317B (en)
SE (1) SE326133B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2121112T3 (en) * 1993-05-14 1998-11-16 Ernst Wolff CONTAINER FOR LIQUIDS OR PASTY SUBSTANCES.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1296884A (en) * 1918-10-07 1919-03-11 Edward J Volk Collapsible tube.
US1739922A (en) * 1927-03-18 1929-12-17 Arthur E Smith Tube closure
US1716802A (en) * 1928-03-19 1929-06-11 Harold C Stevenson Closure for collapsible tubes
GB334314A (en) * 1929-07-01 1930-09-04 John Henry Brown Improvements in or relating to spreaders for collapsible or other containers
US2834520A (en) * 1956-06-15 1958-05-13 Nyden Robert Spouts for containers
DE1766972U (en) * 1957-10-01 1958-05-14 Rudolf Braun CAP FOR ALL TUBES CONTAINING A MUSHY MASS.
AT212769B (en) * 1958-10-03 1961-01-10 Unilever Nv Tube closure
GB868182A (en) * 1958-10-13 1961-05-17 Land W H Improvements in or relating to tube like containers for food and a variety of other substances
FR1354498A (en) * 1962-04-10 1964-03-06 County Lab Ltd Improvements to containers for viscous liquids
FR1351565A (en) * 1962-12-28 1964-02-07 Self-sealing dispensing device for flexible wall receptacles

Also Published As

Publication number Publication date
LU48573A1 (en) 1965-07-12
DE1297536B (en) 1969-06-12
DK113413B (en) 1969-03-17
BE663679A (en) 1965-09-01
SE326133B (en) 1970-07-13
GB1107403A (en) 1968-03-27
CH416451A (en) 1966-06-30
NL6505978A (en) 1965-11-12

Similar Documents

Publication Publication Date Title
Colton et al. 17-Alkyl-19-nortestosterones
NO148662B (en) Conditioning shampoos.
US2590978A (en) Introduction of a double bond adjacent a keto group in ketosteroids
Fishman Rearrangements of Steroidal Ring D Ketols1
US2541104A (en) 17(alpha)-hydroxy-20-ketosteroids and process
Douglas et al. 975. Totally synthetic steroid hormones. Part I. Oestrone and related œstrapolyenes
SCHAUB et al. The synthesis of certain 7α-alkylthio and 7α-acylthio steroid hormone derivatives
US2721871A (en) 17-alkyl derivatives of 19-nortestosterone
Crabbé et al. Steroids. CCCIX. Synthesis of new steroids with unnatural configuration
US3407217A (en) 8-iso-13-polycarbonalkyl gonanes
Mauli et al. Steroids. CXLV. 1 2-Methylandrostane Derivatives. Demonstration of Boat Form in the Bromination of 2α-Methyl-androstan-17β-o1-3-one
US2838530A (en) 17-alkenyl and 17-alkynyl-19-nortestosterones
US3299108A (en) 17alpha-alkynyl/alkenyl-13beta-alkyl-11-alkylgona-1, 3, 5 (10)-triene-3, 17beta-diols, ethers and esters thereof and intermediates thereto
Beereboom et al. Synthesis and Reactions of Chlorinated 3-Ketosteroids
NO118317B (en)
DUSZA et al. 20-Methylpregnane and Derivatives1, 2
US3049555A (en) 3-alkoxy-16-methyl-1, 3, 5 (10)-estratrien-17-ones
KR970005317B1 (en) Derivatives of 19-norprogesterone, methods of producing them and pharmaceutical compositions incorporating them
US2702811A (en) 19-nor-steroids
Djerassi et al. 1-Methyl-19-norprogesterone and 1-Methyl-19-nor-17α-hydroxyprogesterone
Clinton et al. D-Homosteroids. I. Derivatives of D-Homoetiocholan-3α-ol-11, 17a-dione
Zderic et al. Steroids. CXXXVIII. 1 Hydrogenolysis of Hydroxyl Groups in the 3-Phenylcholestanol Series2
SU439973A1 (en) Method for preparing methyl 19-norprogesterone derivative
US3470216A (en) Selected 17,17-difluoro unsaturated androstanes
Romo et al. Steroids. XLI. 1 Synthesis of 11α, 17α-Dihydroxyprogesterone and of 11α, 17α, 21-Trihydroxyprogesterone, the 11-Epimer of Kendall's Compound F2